A new crystalline antibiotic named neopluramycin, which inhibits growth of Gram-positive bacteria, leukemia L-1210 in mice and Yoshida rat sarcoma cells in tissue culture, has been isolated from the cultured broth of a strain of Streptomyces pluricolorescens.
It was obtained as orange crystals, and analytical data and molecular weight determination are consistent with the empirical formula C4oH50N2010. Neopluramycin resembles pluramycin A, but is differentiated by its antibacterial spectrum, toxicity, thin-layer chromatography, and infrared absorption spectrum.
An antibiotic produced by a strain of Streptomyces pluricolorescens was isolated from the cultured broth by solvent extraction.
In exhibits inhibition against Grampositive bacteria, Yoshida rat sarcoma cells and leukemia L-1210 in mice. Taxonomic studies of the streptomyces, isolation and characterization of neopluramycin are discribed in this paper.
The antibiotic was differentiated from known antibiotics and named neopluramycin.
Taxonomy of the Neopluramycin-Producing Strain
The strain was isolated from a soil sample collected in the garden of our institute, 
